The World Heart Federation works to deliver reliable knowledge on the global burden of cardiovascular disease, and information on how it can be managed and prevented in communities around the world.
Our open-access journal, Global Heart, provides a forum for dialogue and education on the prevention, treatment and control of cardiovascular disease worldwide, with a special focus on low resource settings. It publishes research results, points of view and educational material on CVD-related issues.
Visit the Global Heart websiteIn order to better understand the intersection between cardiovascular disease and COVID-19, the World Heart Federation embarked on a global study which aims to better describe cardiovascular outcomes and identify cardiovascular risk factors associated with poor prognosis in patients with COVID-19.
Learn moreThe WHF Salim Yusuf Emerging Leaders Programme was created to form and develop a long-term cadre of experts who collaborate, research and act to reduce premature mortality from cardiovascular disease globally. The Programme, developed by Dr Salim Yusuf in 2014, provides training and networking opportunities in cardiovascular health policy and implementation science for healthcare practitioners, researchers, and global health advocates.
Learn moreFrom 1950 to today, the World Heart Federation’s World Congress of Cardiology (WCC) has been a key event on the cardiovascular calendar, offering a global perspective on cardiovascular health and bringing together thousands of cardiology professionals from all over the world, with the common goal of reducing the global burden of cardiovascular disease.
Learn moreOur Roadmaps are designed and developed by international teams of experts who together identify challenges and offer solutions on specific topics impacting cardiovascular mortality. They can serve as models for regions and countries to develop their own Roadmaps and create or update their national non-communicable disease action plans. They offer a framework to bring together stakeholders with the objective of determining, prioritizing and implementing solutions to reduce premature CVD deaths in any context.
Our CVD Scorecards are designed to track and measure the national response of governments to CVD and monitor progress on implementing CVD prevention and management programmes. They provide a core set of indicators which allow us to understand the epidemiological situation in a country, evaluate the status of CVD programmes, identify policy gaps, and help prioritise advocacy for particular policies or programmes.
Learn moreToday is #PulmonaryHypertensionDay, a moment to raise awareness about pulmonary hypertension (PH). Because its early symptoms, including shortness of breath, chest pain, and dizziness, are frequently misunderstood, PH is frequently diagnosed only in advanced stages. PH, wherein the arteries carrying blood to the lungs develop increased blood pressure, affects both the lungs and the heart. […]
Pulmonary hypertension
Pulmonary hypertension is a life-altering condition that often goes undetected until it’s advanced. This Pulmonary Hypertension Day, let’s shine a light on this silent disease, support early diagnosis, and stand with those living with it every day. Awareness saves lives, because breath is not something we can take for granted. To mark Pulmonary Hypertension Day […]
Pulmonary hypertension
The following statement was prepared by the World Heart Federation in response to the UN Multistakeholder Hearing on NCD’s panel discussion on Reshaping and Strengthening Health Systems and All Forms of Financing to Meet the Needs of People Living With and at Risk of Noncommunicable Diseases and Mental Health Conditions. Distinguished delegates, colleagues and […]
This statement was delivered by Prof. Jagat Narula, President of the World Heart Federation, at the UN Multistakeholder Hearing on NCDs in response to a panel discussion on Tackling the Determinants of Noncommunicable Diseases and Mental Health and Well-Being Through Multisectoral and Effective Governance and Collaborative Action. Distinguished delegates, colleagues and partners, Cardiovascular disease remains […]